Researchers developed small peptide inhibitors to block the spike protein of the SARS-CoV-2 virus. They used a computational approach to design these inhibitors based on the hACE2 protein. The goal was to create molecules that could prevent the virus from entering human cells. The study found that these inhibitors could potentially be used as a treatment for COVID-19.